<strong>Resources</strong>

Title:

Support beyond treatment

Body:

At Pfizer Oncology Together, we’re here to help. Our Care Champions will help you get personalized support—all in one place.* Whether it’s answers to questions or treatment and financial resources, we’re here to offer assistance when you need it most.

Financial Support

Find options to help cover the cost of your medicine— regardless of your insurance coverage.

Support Connections

Connect to local, community, and patient outreach programs that offer comfort and support.

Ongoing Education

Get guidance on living with cancer, including tips on lifestyle, nutrition, and talking with loved ones.

Lodging and Transportation

Learn about local programs that offer help with lodging or transportation while on treatment.

Custom Check-ins

Schedule check-ins that work around you—offering support when you need it and want it.

Workplace Guidance

Receive tools and support to help you prepare for leaving or returning to work after being diagnosed.

Download and print these useful documents. They’ll help educate you about NSCLC, ALK and ROS1 testing, as well as XALKORI. They’ll also prepare you for what to expect while taking XALKORI.

Brochure

This brochure will provide information about XALKORI as a treatment for ALK-positive (ALK+) or ROS1-positve (ROS1+) metastatic NSCLC to help you get the most out of your treatment and understand what to expect.

It's also a good idea to check with your hospital or cancer care team for information about support groups near you.

Third-party websites being linked to are neither owned or controlled by Pfizer.Pfizer does not endorse and is not responsible for the content or services of these sites.

Resources

If you’d like more information about XALKORI® (crizotinib) non-small cell lung cancer (NSCLC) biomarker-driven therapy, or the ALK and ROS1 genes, you may want to start with the following downloads and links.

Important Safety Information & Indications

Indications

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.

Scroll for Important Safety Information

Important Safety Information

XALKORI® (crizotinib) may cause serious side effects, some of which may include:

Liver problems — XALKORI may cause life-threatening liver injury that may lead to death. Your healthcare provider should do blood tests at least every month to check your liver during treatment with XALKORI. Tell your healthcare provider right away if you get any of the following new or worsening symptoms:

yellowing of your skin or the white part of your eyes

severe tiredness

dark or brown (tea color) urine

nausea or vomiting

decreased appetite

pain on the right side of your stomach

bleed or bruise more easily than normal

itching

Lung problems (pneumonitis) — XALKORI may cause life-threatening lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you have any new or worsening symptoms, including:

trouble breathing or shortness of breath

cough with or without mucous

fever

Heart problems — XALKORI may cause very slow, very fast, or abnormal heartbeats. Your healthcare provider may check your heart during treatment with XALKORI. Tell your healthcare provider right away if you feel dizzy or faint or have abnormal heartbeats. Tell your healthcare provider if you take any heart or blood pressure medicines.

Vision problems — Vision problems are common with XALKORI. These problems usually happen within 1 week of starting treatment with XALKORI. Vision problems with XALKORI can be severe and may cause partial or complete loss of vision in one or both eyes. Your healthcare provider may stop XALKORI and refer you to an eye healthcare provider if you develop severe vision problems during treatment with XALKORI. Tell your healthcare provider right away if you have any loss of vision or any change in vision, including:

double vision

seeing flashes of light

blurry vision

light hurting your eyes

new or increased floaters

Before you take XALKORI, tell your healthcare provider if you:

have heart problems, including a condition called long QT syndrome

have liver or kidney problems

have vision or eye problems

have any other medical conditions

are pregnant, or plan to become pregnant. XALKORI can harm your unborn baby.

Females who are able to become pregnant should use effective birth control during treatment with XALKORI and for at least 45 days after the final dose of XALKORI.

Males who have female partners who can become pregnant should use condoms during treatment with XALKORI and for at least 90 days after the final dose of XALKORI.

Talk to your healthcare provider about birth control methods that may be right for you.

If you or your partner becomes pregnant, tell your healthcare provider right away.

are breastfeeding or plan to breastfeed. It is not known if XALKORI passes into your breast milk. Do not breastfeed during treatment with XALKORI and for 45 days after the final dose. Talk to your healthcare provider about the best way to feed your baby during this time.

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.

Indications

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.

Scroll for Important Safety Information

Important Safety Information

XALKORI® (crizotinib) may cause serious side effects, some of which may include:

Liver problems — XALKORI may cause life-threatening liver injury that may lead to death. Your healthcare provider should do blood tests at least every month to check your liver during treatment with XALKORI. Tell your healthcare provider right away if you get any of the following new or worsening symptoms:

yellowing of your skin or the white part of your eyes

severe tiredness

dark or brown (tea color) urine

nausea or vomiting

decreased appetite

pain on the right side of your stomach

bleed or bruise more easily than normal

itching

Lung problems (pneumonitis) — XALKORI may cause life-threatening lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you have any new or worsening symptoms, including:

trouble breathing or shortness of breath

cough with or without mucous

fever

Heart problems — XALKORI may cause very slow, very fast, or abnormal heartbeats. Your healthcare provider may check your heart during treatment with XALKORI. Tell your healthcare provider right away if you feel dizzy or faint or have abnormal heartbeats. Tell your healthcare provider if you take any heart or blood pressure medicines.

Vision problems — Vision problems are common with XALKORI. These problems usually happen within 1 week of starting treatment with XALKORI. Vision problems with XALKORI can be severe and may cause partial or complete loss of vision in one or both eyes. Your healthcare provider may stop XALKORI and refer you to an eye healthcare provider if you develop severe vision problems during treatment with XALKORI. Tell your healthcare provider right away if you have any loss of vision or any change in vision, including:

double vision

seeing flashes of light

blurry vision

light hurting your eyes

new or increased floaters

Before you take XALKORI, tell your healthcare provider if you:

have heart problems, including a condition called long QT syndrome

have liver or kidney problems

have vision or eye problems

have any other medical conditions

are pregnant, or plan to become pregnant. XALKORI can harm your unborn baby.

Females who are able to become pregnant should use effective birth control during treatment with XALKORI and for at least 45 days after the final dose of XALKORI.

Males who have female partners who can become pregnant should use condoms during treatment with XALKORI and for at least 90 days after the final dose of XALKORI.

Talk to your healthcare provider about birth control methods that may be right for you.

If you or your partner becomes pregnant, tell your healthcare provider right away.

are breastfeeding or plan to breastfeed. It is not known if XALKORI passes into your breast milk. Do not breastfeed during treatment with XALKORI and for 45 days after the final dose. Talk to your healthcare provider about the best way to feed your baby during this time.

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.

Patients should always ask their doctors for medical advice about adverse events.

You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (U.S. only)If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly.The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088

The product information provided in this site is intended for residents of the United States.The products discussed herein may have different product labeling in different countries.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

Footer Menu

Important Safety Information

Indications

Indications

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.

Scroll for Important Safety Information

Important Safety Information

XALKORI® (crizotinib) may cause serious side effects, some of which may include:

Liver problems — XALKORI may cause life-threatening liver injury that may lead to death. Your healthcare provider should do blood tests at least every month to check your liver during treatment with XALKORI. Tell your healthcare provider right away if you get any of the following new or worsening symptoms:

yellowing of your skin or the white part of your eyes

severe tiredness

dark or brown (tea color) urine

nausea or vomiting

decreased appetite

pain on the right side of your stomach

bleed or bruise more easily than normal

itching

Lung problems (pneumonitis) — XALKORI may cause life-threatening lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you have any new or worsening symptoms, including:

trouble breathing or shortness of breath

cough with or without mucous

fever

Heart problems — XALKORI may cause very slow, very fast, or abnormal heartbeats. Your healthcare provider may check your heart during treatment with XALKORI. Tell your healthcare provider right away if you feel dizzy or faint or have abnormal heartbeats. Tell your healthcare provider if you take any heart or blood pressure medicines.

Vision problems — Vision problems are common with XALKORI. These problems usually happen within 1 week of starting treatment with XALKORI. Vision problems with XALKORI can be severe and may cause partial or complete loss of vision in one or both eyes. Your healthcare provider may stop XALKORI and refer you to an eye healthcare provider if you develop severe vision problems during treatment with XALKORI. Tell your healthcare provider right away if you have any loss of vision or any change in vision, including:

double vision

seeing flashes of light

blurry vision

light hurting your eyes

new or increased floaters

Before you take XALKORI, tell your healthcare provider if you:

have heart problems, including a condition called long QT syndrome

have liver or kidney problems

have vision or eye problems

have any other medical conditions

are pregnant, or plan to become pregnant. XALKORI can harm your unborn baby.

Females who are able to become pregnant should use effective birth control during treatment with XALKORI and for at least 45 days after the final dose of XALKORI.

Males who have female partners who can become pregnant should use condoms during treatment with XALKORI and for at least 90 days after the final dose of XALKORI.

Talk to your healthcare provider about birth control methods that may be right for you.

If you or your partner becomes pregnant, tell your healthcare provider right away.

are breastfeeding or plan to breastfeed. It is not known if XALKORI passes into your breast milk. Do not breastfeed during treatment with XALKORI and for 45 days after the final dose. Talk to your healthcare provider about the best way to feed your baby during this time.

You should not drink grapefruit juice or eat grapefruit during treatment with XALKORI. It may increase the amount of XALKORI in your blood to a harmful level.

The most common side effects of XALKORI include:

vision problems

nausea

diarrhea

vomiting

swelling of your hands, feet, face, and eyes

constipation

increased liver function blood test results

tiredness

decreased appetite

upper respiratory infection

dizziness

feeling of numbness or tingling in the extremities

XALKORI can cause changes in your vision, dizziness, and tiredness. If you have these symptoms avoid driving a car, using machinery or doing anything that needs you to be alert.

XALKORI may cause decreased fertility. In females, this could affect your ability to become pregnant. In males, this could affect your ability to father a child.

These are not all of the possible side effects of XALKORI. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Indications

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.

CLOSE X

Indications

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.

CLOSE

Terms and Conditions

By enrolling in this co-pay offer, you acknowledge that you currently meet the eligibility criteria and will comply with the Terms and Conditions described below:

The offer is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state healthcare programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico [formerly known as “La Reforma de Salud”]).

The offer is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs, which reimburse you for the entire cost of your prescription drugs.

You are responsible for $10 or the full amount of your co-pay, whichever is less, for each 30-day prescription of a covered medicine. The amount of any savings is the difference between your co-pay and $10. You are entitled to maximum savings of $25,000 per calendar year per patient.

You must deduct the value received under this program from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf.

Cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription.

The offer will be accepted only at participating pharmacies.

This offer is not health insurance.

Offer good only in the United States and Puerto Rico.

Pfizer reserves the right to rescind, revoke, or amend the program without notice.

Program expires 12/31/2017.

No membership fees.

The offer is limited to 1 per person during this offering period and is not transferable.